---
title: RWS Life Sciences - Corporate Translations
description: The LupusQoL has been successfully used in numerous studies with positive results.
---

[![LupusQoL](https://lifesciences.rws.com/hubfs/f1507e55-7e75-46e4-bdb9-8aa70b4490ed.jpg "LupusQoL")](https://lifesciences.rws.com/lupusqol?hsLang=en)

![banner-img1](https://lifesciences.rws.com/hubfs/banner-img1.jpg)

# Clinical Trials

The LupusQoL has been successfully used in numerous studies with positive results. Some of the clinical trials that have used the LupusQoL include:

- [A Study of LY2127399 in Patients With Systemic Lupus Erythematosus](http://clinicaltrials.gov/ct2/show/NCT01205438?term=lupusqol&rank=1)
- [A Study of LY2127399 in Patients With Systemic Lupus Erythematosus](http://clinicaltrials.gov/ct2/show/NCT01196091?term=lupusqol&rank=2)
- [Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (EMBODY 1)](http://clinicaltrials.gov/ct2/show/NCT01262365?term=embody&rank=1)
- [Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (SLE) (EMBODY 2)](http://clinicaltrials.gov/ct2/show/NCT01261793?term=embody&rank=3)
- [Open Label Extension Study of Epratuzumab in Subjects With Systemic Lupus Erythematosus (EMBODY 4)](http://clinicaltrials.gov/ct2/show/NCT01408576?term=embody&rank=2)
- [Study of TRU-015 in Subjects With Membranous Nephropathy Secondary to Systemic Lupus Erythematosus](http://clinicaltrials.gov/ct2/show/NCT00479622?term=3206K3&rank=1)

![RWS Life Sciences](https://lifesciences.rws.com/hubfs/RWS%20Logo%20HERO.png "RWS Life Sciences")

This site is powered by RWS Life Sciences in support of the LupusQoL.